Alnylam Pharmaceuticals, Inc. ALNY announced that the FDA has accepted its new drug application (“NDA”) for its investigational RNAi therapeutic, vutrisiran, being developed for the treatment of adult ...
United Therapeutics UTHR announced that the FDA has issued a complete response letter to its new drug application (“NDA”) for its drug device combination therapy, Tyvaso Dry Powder Inhaler or Tyvaso ...
The NHTSA is upping the pressure on Tesla as the regulator asked for more information about the non-disclosure agreement it made Full Self-Driving Beta testers agree to. The government is also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results